
Bioinformatics has revolutionized medicine by analyzing complex data to uncover disease insights. From cancer subtypes to biomarkers, it aids precision medicine. Despite potential, AI and molecular subtyping adoption in urology faces challenges of cost, workflow, and validation.
Like
Save
Share